Holen Sie sich die Stockscreener-App
3.63
8.04%
0.27
Vorhandelsmarkt:
3.62
-0.010
-0.28%
Schlusskurs vom Vortag:
$3.36
Offen:
$3.38
24-Stunden-Volumen:
1.47M
Relative Volume:
0.62
Marktkapitalisierung:
$392.85M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-258.08M
KGV:
-1.32
EPS:
-2.75
Netto-Cashflow:
$-202.32M
1W Leistung:
+8.68%
1M Leistung:
+15.24%
6M Leistung:
+14.87%
1J Leistung:
-73.13%
1-Tages-Spanne:
$3.36
$3.645
1-Wochen-Bereich:
$3.30
$3.645
52-Wochen-Spanne:
$2.19
$15.00
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Firmenname
Rocket Pharmaceuticals Inc
Sektor
Branche
Telefon
646-440-9100
Adresse
350 FIFTH AVENUE, NEW YORK, NY
Vergleichen Sie RCKT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.63 | 363.63M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-08-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-07-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-30 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-05-28 | Herabstufung | Goldman | Neutral → Sell |
| 2025-05-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-28 | Herabstufung | Jefferies | Buy → Hold |
| 2025-05-28 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-05-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-27 | Herabstufung | Needham | Buy → Hold |
| 2025-05-27 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-03-12 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-12-30 | Eingeleitet | Wedbush | Outperform |
| 2024-12-18 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-04-02 | Eingeleitet | Goldman | Neutral |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-02-01 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-11-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-11-01 | Eingeleitet | BTIG Research | Buy |
| 2022-07-08 | Eingeleitet | Raymond James | Outperform |
| 2021-10-20 | Fortgesetzt | Cowen | Outperform |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
| 2021-02-18 | Eingeleitet | Needham | Buy |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-12-08 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-07-02 | Eingeleitet | JP Morgan | Overweight |
| 2020-06-25 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-06-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2019-11-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-09-26 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-04-23 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-03-15 | Eingeleitet | BofA/Merrill | Buy |
| 2019-02-05 | Eingeleitet | Oppenheimer | Outperform |
| 2018-09-13 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-07-10 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Rocket Pharmaceuticals Inc Aktie (RCKT) Neueste Nachrichten
Rocket Pharmaceuticals (NASDAQ:RCKT) Share Price Passes Below Fifty Day Moving AverageHere's Why - MarketBeat
Rocket Pharmaceuticals (NASDAQ:RCKT) Nasdaq Index Drives Rare-Disease Research - Kalkine Media
What analysts say about Rocket Pharmaceuticals Inc stockConsumer Goods Stocks & Small Entry Cost Investments - earlytimes.in
Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death - MSN
Forecast Cut: Can Rocket Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryPortfolio Gains Report & Free Real-Time Volume Trigger Notifications - BỘ NỘI VỤ
Is Rocket Pharmaceuticals Inc. (9IP1) stock undervalued after correctionJobs Report & High Accuracy Trade Alerts - Newser
What Wall Street predicts for Rocket Pharmaceuticals Inc. Equity Warrant stock price - Newser
Rocket Pharmaceuticals heads to Lisbon for Cardio Genomics Meeting - Traders Union
Is Rocket Pharmaceuticals Inc. (9IP1) stock among top earnings playsWeekly Profit Report & Expert Approved Trade Ideas - Newser
Will Rocket Pharmaceuticals Inc. (9IP1) stock test record highs in 20252025 Big Picture & Growth Oriented Trade Recommendations - Newser
Is Rocket Pharmaceuticals Inc. Equity Warrant stock near bottom after declineWeekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
Is Rocket Pharmaceuticals Inc. stock positioned well for digital economyPortfolio Return Summary & Reliable Volume Spike Alerts - Newser
How Rocket Pharmaceuticals Inc. (9IP1) stock trades pre earnings2025 Volatility Report & Free Expert Verified Stock Movement Alerts - Newser
Is Rocket Pharmaceuticals Inc. (9IP1) stock a buy on weaknessMarket Rally & Daily Stock Trend Watchlist - Newser
Published on: 2025-12-02 03:22:04 - Newser
Published on: 2025-12-02 19:13:04 - BỘ NỘI VỤ
Class Action Alert: Levi & Korsinsky Reminds Rocket (RCKT) Investors of August 11, 2025 Deadline - The National Law Review
Securities Class Action Lawsuit Filed Against Rocket Pharmaceutic - The National Law Review
Rocket Pharmaceuticals Inc (RCKTW) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
How Rocket Pharmaceuticals Inc. Equity Warrant stock performs in weak economyWeekly Trend Recap & Daily Profit Focused Screening - BỘ NỘI VỤ
What is the fair value of Rocket Pharmaceuticals Inc. stock nowInflation Watch & Smart Allocation Stock Reports - moha.gov.vn
Will Rocket Pharmaceuticals Inc. stock deliver consistent dividendsTrade Ideas & High Accuracy Swing Trade Signals - BỘ NỘI VỤ
DEADLINE NEXT WEEK: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit (PR Newswire) - Aktiellt
How buybacks impact Rocket Pharmaceuticals Inc. stock valuePortfolio Gains Report & Weekly Hot Stock Watchlists - BỘ NỘI VỤ
Aug Big Picture: How buybacks impact Rocket Pharmaceuticals Inc. stock valueEarnings Overview Summary & Real-Time Volume Analysis Alerts - BỘ NỘI VỤ
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference - Business Wire
Skyline Ventures India Limited Moves Into Bullish Territory Based on MACDIndustrial Stocks Review & Rapid Wealth Accumulation - earlytimes.in
Why Rocket Pharmaceuticals Inc. Equity Warrant stock could be next big winner2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
Can Rocket Pharmaceuticals Inc. (9IP1) stock sustain revenue momentum2025 Top Decliners & Intraday High Probability Alerts - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock compares with top peersTrade Signal Summary & Technical Pattern Based Signals - newser.com
Is Rocket Pharmaceuticals Inc. stock entering bullish territoryWeekly Trade Summary & AI Enhanced Trade Execution Alerts - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock correlates with oil marketsPrice Action & AI Driven Stock Movement Reports - newser.com
Can Rocket Pharmaceuticals Inc. (9IP1) stock retain market dominance2025 Market Overview & Weekly Market Pulse Updates - newser.com
Amitell Capital Pte Ltd Acquires New Holdings in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Applying big data sentiment scoring on Rocket Pharmaceuticals Inc. Equity WarrantShare Buyback & AI Powered Market Entry Ideas - newser.com
Using R and stats models for Rocket Pharmaceuticals Inc. forecastingQuarterly Market Summary & Daily Stock Trend Watchlist - newser.com
Rocket Pharmaceuticals CEO Sells Shares - TradingView
CEO Shah Sells 6,276 ($18.7K) Of Rocket Pharmaceuticals Inc [RCKT] - TradingView
[Form 4] ROCKET PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Rocket Pharmaceuticals, Inc.Common Stock (Nasdaq:RCKT) Stock Quote - Markets Financial Content
How Rocket Pharmaceuticals Inc. stock reacts to inflationary pressuresWall Street Watch & Safe Capital Growth Tips - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock trades after rate cutsJuly 2025 Sentiment & Risk Controlled Stock Pick Alerts - newser.com
Published on: 2025-11-20 03:46:18 - newser.com
Is Rocket Pharmaceuticals Inc. stock oversold or undervalued2025 Risk Factors & Intraday High Probability Alerts - newser.com
RCKT General Counsel reports 1,646-share stock sale on Form 4 - Stock Titan
Using data models to predict Rocket Pharmaceuticals Inc. Equity Warrant stock movementJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - newser.com
What dividend safety rating applies to Rocket Pharmaceuticals Inc. (9IP1) stock2025 AllTime Highs & Technical Analysis for Trade Confirmation - newser.com
Why Rocket Pharmaceuticals Inc. (9IP1) stock could be next leader2025 Short Interest & Low Drawdown Investment Strategies - newser.com
Is it time to cut losses on Rocket Pharmaceuticals Inc. Equity WarrantTrade Risk Summary & Weekly High Return Stock Opportunities - newser.com
Risk adjusted return profile for Rocket Pharmaceuticals Inc. analyzedWeekly Volume Report & AI Forecast for Swing Trade Picks - newser.com
Rocket Pharmaceuticals Inc. recovery potential after sell off2025 Institutional Moves & Weekly Watchlist for Hot Stocks - newser.com
Finanzdaten der Rocket Pharmaceuticals Inc-Aktie (RCKT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):